These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37711401)

  • 1. European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
    Berenguer M; de Martin E; Hessheimer AJ; Levitsky J; Maluf DG; Mas VR; Selzner N; Hernàndez-Èvole H; Lutu A; Wahid N; Zubair H
    Transpl Int; 2023; 36():11358. PubMed ID: 37711401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
    Claasen MPAW; Sneiders D; Rakké YS; Adam R; Bhoori S; Cillo U; Fondevila C; Reig M; Sapisochin G; Tabrizian P; Toso C
    Transpl Int; 2023; 36():11648. PubMed ID: 37779513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society of Organ Transplantation Consensus Statement on Testing for Non-Invasive Diagnosis of Kidney Allograft Rejection.
    Park S; Sellares J; Tinel C; Anglicheau D; Bestard O; Friedewald JJ
    Transpl Int; 2023; 36():12115. PubMed ID: 38239762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference.
    Berenguer M; Burra P; Ghobrial M; Hibi T; Metselaar H; Sapisochin G; Bhoori S; Kwan Man N; Mas V; Ohira M; Sangro B; van der Laan LJW
    Transplantation; 2020 Jun; 104(6):1143-1149. PubMed ID: 32217940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Sposito C; Cucchetti A; Mazzaferro V
    Dig Dis Sci; 2019 Apr; 64(4):1001-1007. PubMed ID: 30852770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Society of Organ Transplantation (ESOT) Consensus Statement on Prehabilitation for Solid Organ Transplantation Candidates.
    Annema C; De Smet S; Castle EM; Overloop Y; Klaase JM; Janaudis-Ferreira T; Mathur S; Kouidi E; Perez Saez MJ; Matthys C; Dobbels F; Ferrari P; Gołębiewska J; Mrzljak A; Girman P; Perch M; Lopez-Lopez V; White C; Koval D; Greenwood S; Monbaliu D
    Transpl Int; 2023; 36():11564. PubMed ID: 37547750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
    Mehta N; Bhangui P; Yao FY; Mazzaferro V; Toso C; Akamatsu N; Durand F; Ijzermans J; Polak W; Zheng S; Roberts JP; Sapisochin G; Hibi T; Kwan NM; Ghobrial M; Soin A
    Transplantation; 2020 Jun; 104(6):1136-1142. PubMed ID: 32217938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation.
    Norman JS; Li PJ; Kotwani P; Shui AM; Yao F; Mehta N
    J Hepatol; 2023 Dec; 79(6):1469-1477. PubMed ID: 37683735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future).
    Ishizaki Y; Kawasaki S
    J Gastroenterol; 2008; 43(1):18-26. PubMed ID: 18297431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
    Charlton M; Levitsky J; Aqel B; OʼGrady J; Hemibach J; Rinella M; Fung J; Ghabril M; Thomason R; Burra P; Little EC; Berenguer M; Shaked A; Trotter J; Roberts J; Rodriguez-Davalos M; Rela M; Pomfret E; Heyrend C; Gallegos-Orozco J; Saliba F
    Transplantation; 2018 May; 102(5):727-743. PubMed ID: 29485508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N; Tanriover B; Singal AG; Marrero JA
    Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
    Tran BV; Moris D; Markovic D; Zaribafzadeh H; Henao R; Lai Q; Florman SS; Tabrizian P; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Hoteit M; Levine MH; Cillo U; Vitale A; Verna EC; Halazun KJ; Tevar AD; Humar A; Chapman WC; Vachharajani N; Aucejo F; Lerut J; Ciccarelli O; Nguyen MH; Melcher ML; Viveiros A; Schaefer B; Hoppe-Lotichius M; Mittler J; Nydam TL; Markmann JF; Rossi M; Mobley C; Ghobrial M; Langnas AN; Carney CA; Berumen J; Schnickel GT; Sudan DL; Hong JC; Rana A; Jones CM; Fishbein TM; Busuttil RW; Barbas AS; Agopian VG
    Liver Transpl; 2023 Jul; 29(7):683-697. PubMed ID: 37029083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.
    Tabrizian P; Holzner ML; Mehta N; Halazun K; Agopian VG; Yao F; Busuttil RW; Roberts J; Emond JC; Samstein B; Brown RS; Najjar M; Chapman WC; Doyle MM; Florman SS; Schwartz ME; Llovet JM
    JAMA Surg; 2022 Sep; 157(9):779-788. PubMed ID: 35857294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatocellular carcinoma: Management after the transplant.
    Verna EC; Patel YA; Aggarwal A; Desai AP; Frenette C; Pillai AA; Salgia R; Seetharam A; Sharma P; Sherman C; Tsoulfas G; Yao FY
    Am J Transplant; 2020 Feb; 20(2):333-347. PubMed ID: 31710773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
    Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
    Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection.
    Chan KM; Wu TH; Cheng CH; Lee CF; Wu TJ; Chou HS; Lee WC
    Biomed J; 2019 Oct; 42(5):335-342. PubMed ID: 31783994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Transplantation for High Risk Hepatocellular Carcinoma After Liver Resection: A Sequential or Salvage Approach?
    Lin CC; Elsarawy AM; Li WF; Lin TL; Yong CC; Wang SH; Wang CC; Kuo FY; Cheng YF; Chen CL
    Ann Transplant; 2017 Oct; 22():602-610. PubMed ID: 28993607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.